ELIZABETH MAECHLER: Open Payments
NPI 1134907637 · FORT SMITH, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,516 in 79 payments from 14 companies in 2025. Trend: 2023 $28 · 2024 $358 · 2025 $1,516
Food & beverage: $1,416Education: $100
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 16 | $281 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $264 |
| Novartis Pharmaceuticals Corporation | 9 | $212 |
| ABBVIE INC. | 18 | $195 |
| GENZYME CORPORATION | 3 | $183 |
| Regeneron Healthcare Solutions, Inc. | 5 | $114 |
| UCB, Inc. | 5 | $87 |
| LEO Pharma Inc. | 3 | $62 |
| PFIZER INC. | 2 | $32 |
| Amgen Inc. | 1 | $20 |
Products named: DUPIXENT, TALTZ, COSENTYX, SKYRIZI, ILUMYA, Bimzelx, EBGLYSS, ANZUPGO.
Industry payments across AR — which companies pay providers there.
